OG article by Megan Henry December 22, 2025 Ohio Governor Mike DeWine signed Senate Bill 56 into law on December 19, 2025, enacting a ban on intoxicating hemp products and introducing modifications to the state's voter-approved recreational marijuana regulations. The legislation, effective in 90 days, aligns with recent federal changes by prohibiting the sale of intoxicating hemp outside licensed marijuana dispensaries and banning products exceeding 0.4 milligrams of total T

OG article by Mills Hayes, Michael Ramsey December 22, 2025 A U.S. executive from ScottsMiracle-Gro, whose Hawthorne Gardening Company supplies equipment to cannabis growers, described a closed-door Oval Office meeting on December 9, 2025, where President Donald Trump decided to roll back restrictions on marijuana. The meeting, lasting two hours and 15 minutes, involved intense arguments among advocates and opponents of reclassifying marijuana from Schedule I to Schedule III

OG article by Chris Roberts December 22, 2025 President Donald Trump issued an executive order directing Attorney General Pam Bondi to reschedule marijuana as a Schedule 3 drug in the most expeditious manner under federal law. This follows a process initiated under former President Joe Biden in October 2022, which included paused hearings and an August 2023 Health and Human Services finding that cannabis has a currently accepted medical use. The $32 billion U.S. cannabis ind

OG article by Sean Williams December 22, 2025 President Donald Trump signed an executive order on December 18, 2025, to accelerate the Food and Drug Administration's review of reclassifying cannabis from a Schedule I to a Schedule III substance under the Controlled Substances Act. This follows a 2023 recommendation from the Department of Health and Human Services, aiming to recognize cannabis's medical benefits and facilitate research into medical marijuana and cannabidiol t

OG article by KN December 22, 2025 The UAE Government has issued a Federal Decree-Law to regulate the industrial and medical uses of industrial hemp, establishing a new economic sector for sustainable development. This enables applications in textiles, construction, paper, packaging, and authorized medical products, while aligning with international best practices. The Decree-Law strictly prohibits personal, recreational, or unauthorized uses of industrial hemp, including in

OG article by Rob Carpenter December 22, 2025 The Trump administration is considering rescheduling marijuana from Schedule I to Schedule III under the Controlled Substances Act, which could eliminate the Department of Transportation's (DOT) authority to test commercial drivers for cannabis. This change would stem from Department of Health and Human Services (HHS) guidelines that authorize testing only for Schedule I and II substances, potentially removing marijuana from the

OG article by KN/DUBAI/its illegal to talk about the government there so it doesn't say December 19, 2025 The UAE government issued a Federal Decree-Law amending provisions of the Federal Decree-Law on Combating Narcotic Drugs and Psychotropic Substances to strengthen community protection, uphold justice, safeguard rights, and enhance the national framework for combating narcotics in line with high regulatory, health, and security standards. The amendments align with develop

OG article by Jahan Marcu December 19, 2025 Beverages have historically shaped societies beyond hydration, organizing rituals and revolutions—from juice as portable pleasure to tea's empire-building, coffee's dissent hubs, and chocolate's scapegoating for moral fears. Now, canned THC beverages emerge: low-dose, carbonated, fruit-flavored, euphoric without smoke or stigma, blending happy hour with dispensaries. Fans see moderation—calm, enhanced appetite, connection sans dama

OG article by Anthony Martinelli December 19, 2025 A study in the Journal of Neuroscience Research suggests cannabidiol (CBD) may shield the brain from acrylamide, a pollutant formed in high-temperature cooking like frying and baking. Conducted by University of Patras scientists on male mice, it tested CBD against acrylamide's neurotoxicity, which crosses the blood-brain barrier, causing oxidative stress, inflammation, and signaling disruptions linked to neurodegeneration. A

OG article by Jenny Lamboy December 19, 2025 The federal ban on intoxicating hemp products has sparked uncertainty, with a 365-day grace period interpreted as either an extension of the 2018 Farm Bill loophole or a strict sell-through deadline by mid-November 2026. This divide fuels in-fighting between intoxicating hemp and regulated cannabis sectors, evident at conferences where the ban drew applause from cannabis advocates. Market data from BDSA values the U.S. intoxicatin

OG article by Executive Orders December 19, 2025 This executive order aims to boost research on medical marijuana and cannabidiol (CBD) to bridge gaps in federal policy and scientific understanding. It notes that chronic pain affects one in four U.S. adults and one in three seniors, with six in ten medical marijuana users targeting pain relief. Forty states and D.C. have regulated programs, yet Schedule I classification under the CSA has hindered research. HHS's 2023 recomme

OG article by Khloe Quill December 19, 2025 A comprehensive review published in JAMA analyzed over 2,500 scientific papers from the past 15 years on medical cannabis, revealing limited evidence supporting its effectiveness for most conditions. Led by UCLA researchers with contributions from Harvard, UC San Francisco, Washington University, and New York University, the study highlights significant gaps between public perception and scientific proof. Dr. Michael Hsu, the lead